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In This IssueDeubiquitination Keeps Oncogene in Check
PAGE 665
Mutations in CYLD, a deubiquitinating enzyme, cause tumors that originate from hair
follicle keratinocytes. Massoumi et al. show that the wild-type CYLD prevents the
formation of tumors by deubiquitinating the oncogene Bcl-3, thereby denying it access
to the nucleus. In mice lacking CYLD, Bcl-3 accumulates in the nucleus and stimulates
proliferation by binding to members of the NF-kB family of transcription factors. This
study is the first demonstration of a specificmechanism bywhich Bcl-3 is kept in check.
Structure of a Histone Demethylase
PAGE 691
Histone demethylases remove methyl groups from the lysine residues of histone tails and thereby contribute to transcrip-
tional regulation of target genes. The JmjC-containing protein JMJD2A has been characterized as a site-specific histone
tri-methyl demethylase. Here, Chen et al. report the crystal structure of the core catalytic domain of JMJD2A, defining
unique elements that form a potential substrate binding pocket. The structure, combined with additional biochemical ex-
periments, provides insight into themolecular mechanism of substrate selection by the JMJD2 histone demethylase family.
FACT-Check on Transcription Elongation
PAGE 703
RNA polymerase II must overcome the nucleosomal barriers present in chromatin to synthesize RNA. Pavri et al. designed
a fully reconstituted chromatin and transcription system to define the minimal factors required for transcription elongation.
In conjunction with the histone chaperone FACT, monoubiquitination of histone H2B at lysine 120 is required for robust and
efficient transcription elongation. This histonemodification impacts on the extent of transcript elongation in a FACT-depen-
dent manner facilitating RNA polymerase migration along the transcription unit. These studies identify the functional rele-
vance of one of the several histone modifications that positively regulate transcription.
A Key to the Mitotic Exit Door
PAGE 719
Following chromosome segregation, cells have to exit mitosis and undergo cytokinesis before entering G1 of the next cell
cycle. Although we have a relatively good grasp of the regulation of mitotic entry—driven by upregulation of mitotic
kinases—the control of mitotic exit is still much less understood. In budding yeast, Queralt et al. show that the protease
that separates sister chromatids, separase, interacts with and downregulates PP2ACdc55 phosphatase. Downregulation
of PP2A allows mitotic kinases to activate their own key antagonist, the phosphatase Cdc14. Thus, separase provides
an early impetus to inhibit mitotic kinase activity, a key event required for mitotic exit.
Homing in on DNA Damage in Prokaryotes
PAGE 679
The elaborate DNA repair machinery of eukaryotic cells has been studied intensively, but the
machinery in prokaryotes is less well understood. Bejerano-Sagie et al. now show that the
DisA protein expressed during an early stage of sporulation in the bacterium Bacillus subtilis
acts as a DNA-damage checkpoint protein. DisA molecules are organized into a single focal
assembly that moves dynamically within the bacterial cell searching for DNA lesions. When
damage is encountered, the DisA assembly pauses at the lesion site. The stalled complex de-
lays sporulation, enabling the damage to be repaired. This study provides new insights into
how proteins proofread DNA in prokaryotic cells and activate a developmental checkpoint
response.Cell 125, May 19, 2006 ª2006 Elsevier Inc. 621
Picky PI3 Kinase Inhibitors
PAGE 733
Phosphoinositide 3-kinases (PI3-Ks) have been implicated in diverse physiological processes including cell growth and
intracellular trafficking, but the unique roles of the various PI3-K isoforms are unclear. Knight et al. describe a panel of
isoform-specific PI3-K inhibitors and reveal the structural basis for their selectivity by solving the crystal structures of three
inhibitors bound to the PI3-K isoform p110gamma. Using the inhibitors, the authors find that the isoform p110alpha is
required for insulin signaling. These experiments illustrate how selective pharmacology can be used to dissect the function
of different kinase isoforms and provide new insights into the regulation of insulin signaling.
Astrocytic Serine Assists Synapses
PAGE 775
A central player in excitatory synaptic transmission is the NMDA receptor, which requires
both glutamate and a coagonist, such asD-serine, for activity. Panatier et al. now show that
astrocytes, a type of glial cell, control NMDA receptor activity in neurons through the syn-
thesis and release of D-serine. The authors examine the activity of rat hypothalamic neu-
rons, whose coverage by astrocytes changes during lactation. They show that the degree
of astrocytic coverage determines NMDA receptor and synaptic activity. These results es-
tablish the active contribution of astrocytes to synaptic transmission in the brain.
PAMP Receptor Transfers Immunity
PAGE 749
Innate immunity in higher eukaryotes involves the recognition of pathogen-associated molecular patterns (PAMPs) by spe-
cific receptors. Zipfel et al. now identify theArabidopsisPAMP receptor for an elongation factor (EF-Tu) fromAgrobacterium
tumefaciens, a bacterium that infects many crops, causing tumor-like growths. The authors find that Arabidopsis mutants
lacking this receptor are more susceptible to Agrobacterium infection, while expression of the receptor in tobacco plants,
which normally lack the receptor, allows them to mount an immune response. The findings thus suggest an approach for
making crops more resistant to Agrobacterium infection.
Classic Coactivator Steps out of the Nucleus
PAGE 761
OCA-B, a cell type-specific transcriptional coactivator, is critical for antigen-dependent immune responses in B cells. Now
Siegel et al. show that OCA-B not only regulates expression of its transcriptional targets within the nucleus, but also func-
tions in signaling pathways involving the SYK kinase, which has critical roles in both pre-B and B cell signaling. OCA-B
binds to SYK and regulates its stability in the cytoplasm of pre-B cells. These findings indicate a new and unexpected func-
tion of a classic coactivator in B cell development.
The Mighty ‘‘Minis’’’
PAGE 785
When neuronal action potentials are blocked, synaptic strength slowly increases to compensate. Now, Sutton et al. show
that miniature synaptic transmissions or ‘‘minis,’’ which release neurotransmitter independent of action potentials, shape
this compensatory response. When both ‘‘minis’’ and action potentials are blocked, the compensatory upregulation of
synaptic strength is accelerated due to an increase in protein synthesis in postsynaptic dendrites. Thus, these results
indicate that ‘‘minis’’ stabilize synaptic function by suppressing local protein synthesis in dendrites.
Attacking the Ataxia Protein Network
PAGE 801
Several inherited cerebellar ataxias share clinical and pathological features, most notably,
loss of balance and Purkinje cell degeneration. Over 20 ataxia-causing genes have been
identified, but whether the corresponding proteins are functionally related was not known.
Lim and colleagues developed a protein-protein interaction network for 23 ataxia-causing
proteins. Surprisingly, they found that the majority (18/23) of the ataxia proteins interact,
and that several genetic modifiers of the phenotypes are also physical interactors of the
ataxia proteins. This study reveals that the protein interaction network for ataxia is highly
interconnected and provides a novel approach to study complex disorders.Cell 125, May 19, 2006 ª2006 Elsevier Inc. 623
